These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29713029)

  • 1. How we approach it: treatment options for hepatocellular carcinoma.
    Hernaez R; El-Serag HB
    Am J Gastroenterol; 2018 Jun; 113(6):791-794. PubMed ID: 29713029
    [No Abstract]   [Full Text] [Related]  

  • 2. TATI modality: A new perspective on the treatment of advanced hepatocellular carcinoma.
    Li X; Liang P; Ye X
    J Cancer Res Ther; 2020 Sep; 16(5):957-959. PubMed ID: 33004734
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocellular carcinoma: status in the era of liver transplantation.
    Singhal A; Jabbour N
    J Okla State Med Assoc; 2009 Dec; 102(12):355-61. PubMed ID: 20131731
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Vogel A; Cervantes A; Chau I; Daniele B; Llovet JM; Meyer T; Nault JC; Neumann U; Ricke J; Sangro B; Schirmacher P; Verslype C; Zech CJ; Arnold D; Martinelli E;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv238-iv255. PubMed ID: 30285213
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in Hepatocellular Carcinoma.
    Frenette C
    Clin Liver Dis; 2020 Nov; 24(4):xiii-xiv. PubMed ID: 33012459
    [No Abstract]   [Full Text] [Related]  

  • 6. Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization.
    Reichman TW; Anthony T; Millis JM; Testa G
    Dig Liver Dis; 2009 Feb; 41(2):175-6. PubMed ID: 18849205
    [No Abstract]   [Full Text] [Related]  

  • 7. What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?
    Dirican A; Karakas S
    J Gastrointest Cancer; 2020 Dec; 51(4):1148-1151. PubMed ID: 32839945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma.
    Morante A; Romano M; Cuomo A; de Sio I; Cozzolino A; Mucherino C; Salerno R; Blanco Cdel V; Romano M
    Gastrointest Endosc; 2006 Apr; 63(4):718-20. PubMed ID: 16564887
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatocellular carcinoma in children.
    Kelly D; Sharif K; Brown RM; Morland B
    Clin Liver Dis; 2015 May; 19(2):433-47. PubMed ID: 25921672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Geschwind JF; Chapiro J
    Clin Adv Hematol Oncol; 2016 Aug; 14(8):585-7. PubMed ID: 27487101
    [No Abstract]   [Full Text] [Related]  

  • 11. [Palliative treatment for hepatocellular carcinoma].
    Raoul JL; Gilabert M; Oziel-Taïeb S; Giovannini M
    Rev Prat; 2013 Feb; 63(2):233-6. PubMed ID: 23513793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: options for diagnosing and managing a deadly disease.
    Murali AR; Romero-Marrero C; Aucejo F; Menon KV
    Cleve Clin J Med; 2013 Oct; 80(10):645-53. PubMed ID: 24085810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma (primary cancer of the liver).
    Barbare JC; Boige V; Boudjema K; Lescesne R; Trinchet JC
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S57-2S61. PubMed ID: 17151564
    [No Abstract]   [Full Text] [Related]  

  • 14. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
    Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
    World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver tumors and loco-regional therapy.
    Vogel W
    Wien Med Wochenschr; 2013 Mar; 163(5-6):107-8. PubMed ID: 23456251
    [No Abstract]   [Full Text] [Related]  

  • 16. Gender-Related Differences in Hepatocellular Carcinoma: Does Sex Matter?
    Kohi MP
    J Vasc Interv Radiol; 2016 Sep; 27(9):1338-1341. PubMed ID: 27566425
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatocellular carcinoma: epidemic and treatment.
    Allen J; Venook A
    Curr Oncol Rep; 2004 May; 6(3):177-83. PubMed ID: 15066228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver rupture after transcatheter arterial chemoembolization of a giant hepatocellular carcinoma.
    Pijl ME; Pattynama PM; van Hoek B
    J Vasc Interv Radiol; 1999; 10(7):895-7. PubMed ID: 10435707
    [No Abstract]   [Full Text] [Related]  

  • 19. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging features following transarterial chemoembolization and radiofrequency ablation of hepatocellular carcinoma.
    Brennan IM; Ahmed M
    Semin Ultrasound CT MR; 2013 Aug; 34(4):336-51. PubMed ID: 23895906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.